Daiichi Sankyo (OTCMKTS:DSNKY) Sets New 12-Month Low – What’s Next?

Shares of Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY) reached a new 52-week low during mid-day trading on Monday . The company traded as low as $17.14 and last traded at $17.31, with a volume of 1861 shares trading hands. The stock had previously closed at $17.77.

Daiichi Sankyo Price Performance

The business’s 50-day simple moving average is $18.45 and its 200-day simple moving average is $21.34. The stock has a market cap of $33.04 billion, a PE ratio of 16.00, a PEG ratio of 0.90 and a beta of -0.04. The company has a quick ratio of 1.85, a current ratio of 2.69 and a debt-to-equity ratio of 0.18.

Daiichi Sankyo (OTCMKTS:DSNKY) last announced its earnings results on Thursday, January 29th. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.05. The firm had revenue of $3.65 billion for the quarter, compared to analyst estimates of $3.88 billion. Daiichi Sankyo had a net margin of 14.83% and a return on equity of 18.64%. On average, research analysts expect that Daiichi Sankyo Co., Ltd. – Sponsored ADR will post 0.73 EPS for the current fiscal year.

About Daiichi Sankyo

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.